首页>
外国专利>
Activin Receptor Type II B inhibitors including extracellular domain of delta-like 1 homolog
Activin Receptor Type II B inhibitors including extracellular domain of delta-like 1 homolog
展开▼
机译:激活素受体II B型抑制剂,包括δ样1同源物的胞外域
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to an activin receptor type II B (ACVR2B) inhibitor which comprises the delta-like 1 homolog (DLK1) extracellular water-soluble domain. More specifically, the present invention relates to an extracellular soluble domain of DLK1; fragments of the extracellular soluble domain of DLK1; mutants of the extracellular soluble domain of DLK1; a composition for suppressing ligand linkage with the ACVR2B receptor, which includes a fragment of the mutants as an active ingredient; and a pharmaceutical composition for prevention and treatment of diseases which comprises the same. The composition of the present invention competitively binds to the ACVR2B receptor and inhibits the binding of an ACVR2B ligand to the ACVR2B receptor, which inhibits protein signalling associated with such ligands, and will be useful for prevention and treatment of diseases associated therewith.
展开▼